MedTrace Logo

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

NCT00900055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 213

Last updated 2022-07-05

No results posted yet for this study

Summary

RATIONALE: Analyzing tissue and blood samples from healthy volunteers or patients with Fanconi anemia, myelodysplasia, myeloproliferative disorders, or myeloma in the laboratory may help doctors learn more about the causes of blood cancers.

PURPOSE: The purpose of this study is to analyze in the laboratory blood and bone marrow cells from healthy volunteers or patients with Fanconi anemia, myeloproliferative disorders, or myeloma.

Conditions

  • Chronic Myeloproliferative Disorders
  • Fanconi Anemia
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Myelodysplastic/Myeloproliferative Neoplasms

Interventions

GENETIC

microarray analysis

GENETIC

polyacrylamide gel electrophoresis

GENETIC

polymerase chain reaction

GENETIC

protein expression analysis

GENETIC

reverse transcriptase-polymerase chain reaction

GENETIC

western blotting

OTHER

chromatography

OTHER

high performance liquid chromatography

OTHER

immunoenzyme technique

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • OHSU Knight Cancer Institute

    lead OTHER

Principal Investigators

  • Laura Newell, MD · OHSU Knight Cancer Institute

Eligibility

Min Age
1 Year
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1975-06-30
Primary Completion
2016-08-23
Completion
2016-08-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00900055 on ClinicalTrials.gov